尿血管緊張素原與慢性腎臟病的關(guān)聯(lián)研究
發(fā)布時(shí)間：2018-08-01 13:25
【摘要】：目的:探討尿血管緊張素原(AGT)與慢性腎臟病(CKD)的關(guān)聯(lián)性,探討尿AGT對(duì)慢性腎臟病的診斷的意義。方法:從慢性腎臟病橫斷面調(diào)查的資源標(biāo)本庫(kù)中抽取CKD和非CKD樣本,按照估算的腎小球?yàn)V過(guò)率(eGFR單位:ml/min/1.73m2)將CKD患者分為3組:正常組(eGFR≥90),臨界組(60≤eGFR90),下降組(30≤eGFR60)。CKD組和非CKD組中在收縮壓80-220mmHg區(qū)間,按每隔20 mmHg進(jìn)行分組。尿AGT用酶聯(lián)免疫吸附測(cè)定法(ELISA)進(jìn)行檢測(cè)。單因素方差分析法分析組間差異,多因素分析采用多重線(xiàn)性回歸分析法。結(jié)果:資料完整的95名CKD患者和413名非CKD對(duì)照組進(jìn)入本研究。CKD組尿AGT明顯高于非CKD組(243.97±47.86 vs 158.43±25.14t=16.892 P0.01);隨著腎小球?yàn)V過(guò)率下降,尿AGT呈升高趨勢(shì),正常組、臨界組和下降組尿AGT分別為213.63±34.47ng/L,251.39±17.17ng/L,314.97±27.58ng/L,各組間有顯著差異(F=81.103 P0.01)。在同一血壓水平下,CKD組中尿AGT均顯著高于非CKD組,差異有統(tǒng)計(jì)學(xué)意義(P0.01);CKD組中隨著收縮壓升高,尿AGT水平進(jìn)一步升高,收縮壓在140-160mmHg和160-180mmHg區(qū)間段,差異有統(tǒng)計(jì)學(xué)意義(P0.01)。多重線(xiàn)性回歸分析顯示,尿AGT與尿白蛋白/肌酐和血肌酐呈正相關(guān),與eGFR呈負(fù)相關(guān)。結(jié)論:慢性腎臟病患者尿AGT高于非CKD者;在CKD患者中隨著收縮壓升高,尿AGT水平進(jìn)一步升高;尿AGT與尿白蛋白/肌酐和血肌酐呈正相關(guān),與eGFR呈負(fù)相關(guān);提示尿血管緊張素原可作為慢性腎臟病早期預(yù)測(cè)和病程進(jìn)展的生物學(xué)標(biāo)志物。
[Abstract]:Objective: To investigate the association between urinary angiotensinogen (AGT) and chronic renal disease (CKD), and to explore the significance of urinary AGT in the diagnosis of chronic renal disease. Methods: CKD and non CKD samples were extracted from the resource Specimen Bank of the cross-sectional study of chronic kidney disease, and CKD patients were divided into 3 groups according to the estimated glomerular filtration rate (eGFR unit: ml/min/1.73m2). Group (eGFR > 90), critical group (60 < < eGFR90), decreased group (30 < eGFR60).CKD and non CKD group in systolic pressure 80-220mmHg interval, every 20 mmHg were grouped. Urine AGT was detected by enzyme linked immunosorbent assay (ELISA). Single factor analysis of variance analysis was used to analyze the difference between groups and multiple linear regression analysis was adopted. The urine AGT of 95 CKD patients and 413 non CKD controls was significantly higher than that in the non CKD group (243.97 + 47.86 vs 158.43 + 25.14t=16.892 P0.01). With the decrease of the glomerular filtration rate, the urine AGT showed a tendency to increase. The normal group, the critical group and the descending group of AGT were 213.63 + 34.47ng/L, 251.39 + 17.17ng/L, 314.97 +, respectively. There were significant differences between each group (F=81.103 P0.01). In the same blood pressure level, the urine AGT in CKD group was significantly higher than that in the non CKD group, and the difference was statistically significant (P0.01). In the CKD group, the level of urinary AGT increased with the increase of systolic pressure, and the systolic pressure was in the 140-160mmHg and 160-180mmHg segments, the difference was statistically significant (P0.01). Multiple linear regression scores were found in group CKD. The results showed that urinary AGT was positively correlated with urinary albumin / creatinine and creatinine and negatively correlated with eGFR. Conclusion: the urine AGT of patients with chronic kidney disease is higher than that of non CKD; in patients with CKD, the level of urine AGT increases with the increase of systolic pressure; urinary AGT is positively related to urinary albumin / creatinine and creatinine, and is negatively related to eGFR, suggesting urinary angiotensinogen. It can be used as a biomarker for early prediction and progression of chronic kidney disease.
【學(xué)位授予單位】：新疆醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R692
本文編號(hào)：2157723
[Abstract]:Objective: To investigate the association between urinary angiotensinogen (AGT) and chronic renal disease (CKD), and to explore the significance of urinary AGT in the diagnosis of chronic renal disease. Methods: CKD and non CKD samples were extracted from the resource Specimen Bank of the cross-sectional study of chronic kidney disease, and CKD patients were divided into 3 groups according to the estimated glomerular filtration rate (eGFR unit: ml/min/1.73m2). Group (eGFR > 90), critical group (60 < < eGFR90), decreased group (30 < eGFR60).CKD and non CKD group in systolic pressure 80-220mmHg interval, every 20 mmHg were grouped. Urine AGT was detected by enzyme linked immunosorbent assay (ELISA). Single factor analysis of variance analysis was used to analyze the difference between groups and multiple linear regression analysis was adopted. The urine AGT of 95 CKD patients and 413 non CKD controls was significantly higher than that in the non CKD group (243.97 + 47.86 vs 158.43 + 25.14t=16.892 P0.01). With the decrease of the glomerular filtration rate, the urine AGT showed a tendency to increase. The normal group, the critical group and the descending group of AGT were 213.63 + 34.47ng/L, 251.39 + 17.17ng/L, 314.97 +, respectively. There were significant differences between each group (F=81.103 P0.01). In the same blood pressure level, the urine AGT in CKD group was significantly higher than that in the non CKD group, and the difference was statistically significant (P0.01). In the CKD group, the level of urinary AGT increased with the increase of systolic pressure, and the systolic pressure was in the 140-160mmHg and 160-180mmHg segments, the difference was statistically significant (P0.01). Multiple linear regression scores were found in group CKD. The results showed that urinary AGT was positively correlated with urinary albumin / creatinine and creatinine and negatively correlated with eGFR. Conclusion: the urine AGT of patients with chronic kidney disease is higher than that of non CKD; in patients with CKD, the level of urine AGT increases with the increase of systolic pressure; urinary AGT is positively related to urinary albumin / creatinine and creatinine, and is negatively related to eGFR, suggesting urinary angiotensinogen. It can be used as a biomarker for early prediction and progression of chronic kidney disease.
【學(xué)位授予單位】：新疆醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R692
【參考文獻(xiàn)】
相關(guān)期刊論文 前6條
1 吳海燕;梁耀先;鄭亦沐;白瓊;莊震;阿拉塔;鄭丹俠;王悅;;高鹽飲食上調(diào)腎局部腎素-血管緊張素系統(tǒng)參與大鼠高血壓腎損害的發(fā)生[J];北京大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2015年01期
2 莊震;白瓊;阿拉塔;史均寶;鄭丹俠;王悅;;尿血管緊張素原在不伴高血壓的糖尿病患者腎損害中的意義[J];中國(guó)血液凈化;2013年06期
3 趙譚;孫樹(shù)印;吳玉梅;;糖尿病腎病患者血 尿血管緊張素原的測(cè)定及意義[J];濟(jì)寧醫(yī)學(xué)院學(xué)報(bào);2013年02期
4 章曉燕;呂文律;滕杰;鐘一紅;丁小強(qiáng);;慢性腎臟病患者尿血管緊張素原與腎臟腎素血管緊張素系統(tǒng)活性的相關(guān)性[J];中華腎臟病雜志;2011年05期
5 迪力木拉提;李增錄;劉健;艾孜子;安尼瓦;劉珍;王芳;王海燕;;新疆墨玉縣農(nóng)村維吾爾族成人慢性腎臟病流行病學(xué)調(diào)查[J];中華腎臟病雜志;2009年08期
6 張路霞;左力;徐國(guó)賓;王芳;王淑玉;王梅;呂繼成;張軍茹;劉力生;王海燕;;北京市石景山地區(qū)中老年人群中慢性腎臟病的流行病學(xué)研究[J];中華腎臟病雜志;2006年02期
，本文編號(hào)：2157723
本文鏈接：http://www.sikaile.net/yixuelunwen/mjlw/2157723.html
最近更新
教材專(zhuān)著
